Detalhe da pesquisa
1.
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Lupus
; 33(4): 340-346, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334100
2.
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
Lupus
; 32(5): 658-667, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916674
3.
Factors associated with neuropsychiatric involvement in Latin American patients with systemic lupus erythematosus.
Lupus
; 30(9): 1481-1491, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082589
4.
Expression and clinical implications of HLA-G and PD-L1 following kidney transplantation: A cohort study.
Medicine (Baltimore)
; 102(46): e36053, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986370
5.
Mycoplasmal lipid-associated membrane proteins and Mycoplasma arthritidis mitogen recognition by serum antibodies from patients with rheumatoid arthritis.
Rheumatol Int
; 31(7): 951-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21052674
6.
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
RMD Open
; 6(3)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33310863
7.
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
J Rheumatol
; 46(10): 1299-1308, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824636
8.
Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
Semin Arthritis Rheum
; 45(6): 675-83, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26698222
9.
Efecto de los antimaláricos sobre los diferentes dominios del índice de daño SLICC en pacientes de la cohorte GLADEL / Effect of antimalarials on the different domains of the SLICC damage index in patients of the GLADEL cohort
Rev. argent. reumatol
; 29(3): 6-10, set. 2018. tab
Artigo
em Espanhol
| LILACS | ID: biblio-977290
10.
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
Arthritis Rheum
; 58(10): 2968-80, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18821691